ArticleBMC pulmonary medicine2023

Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country.

Mahdieh Fathi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.